Laia Fernández‐Barat

This paper evaluates a non-antibiotic live biotherapeutic for treating Pseudomonas aeruginosa ventilator-associated pneumonia in preclinical models, showing reduced biofilm and bacterial load with improved safety and immunomodulatory effects.

Brewpitopes refines B-cell epitope predictions by integrating protein features, improving neutralizing epitope identification in SARS-CoV-2.